{"id":"tp-40650","type":"article-newspaper","title":"Genmab and Incyte Plan Phase 1/2 Trial for KRAS-Mutated Metastatic Colorectal Cancer","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/40650","datePublished":"2026-10-25T19:04:15.000Z","dateModified":"2026-10-25T19:04:15.000Z","language":"en","abstract":"The study will combine petosemtamab and INCB161734 with chemotherapy as a potential first-line treatment.","section":"Business","references":[]}